KEUNSUN AHN,
CEO
Keunsun Ahn received B.S. in Mechanical Engineering from Soongsil University(South Korea) and M.S. in Mechanical Engineering(3D printing and Tissue Engineering) from Pohang University of Science and Technology(POSTECH, South Korea). K. Ahn has a lot of research and development(R&D) experiences in bio/medical applications of 3D printing/Bioprinting technology, and had worked for T&R Biofab Co., Ltd., a representative startup in South Korea, and conducted R&D in the field of 3D bioprinter development and bio-printed cell therapy. Since then, K. Ahn has been commercializing cell spheroid production automation and spheroid-derived extracellular vesicle production technology as Founder & CEO of SPHEBIO Co., Ltd., which is established in 2020. K. Ahn have published 50 domestic/international patents and 20 journal papers.
|
|
|
